Comparative study of bone turnover and BMD response to treatment with risedronate, vitamin D, or vitamin K in Japanese osteoporosis patients.

被引:0
|
作者
Iwata, H [1 ]
Yamada, S [1 ]
Takagi, H [1 ]
机构
[1] Nagoya Kyoritsu Hosp, Rheumatol & Joint Replacement Ctr, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S283 / S284
页数:2
相关论文
共 50 条
  • [21] Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Suzuki, Takako
    Nakamura, Yukio
    Tanaka, Mizue
    Kamimura, Mikio
    Ikegami, Shota
    Uchiyama, Shigeharu
    Kato, Hiroyuki
    MODERN RHEUMATOLOGY, 2018, 28 (02) : 376 - 379
  • [22] Accelerated bone turnover in vitamin D-deficient patients
    Aylward, KE
    Healy, M
    Casey, M
    Walsh, JB
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1308 - 1308
  • [23] Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
    Sahota, O
    Masud, T
    San, P
    Hosking, DJ
    CLINICAL ENDOCRINOLOGY, 1999, 51 (02) : 217 - 221
  • [24] A convenient new approach to simplify osteoporosis treatment regimen for risedronate plus calcium and vitamin D
    Fardellone, P.
    Varbanov, A.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S125 - S125
  • [25] A convenient new approach to simplify osteoporosis treatment regimen for risedronate plus calcium and vitamin D
    Fardellone, P.
    Varbanov, A.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S155 - S156
  • [26] EFFECT OF VITAMIN D THERAPY ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOPENIA
    Tanzy, Margaret E.
    Camacho, Pauline M.
    ENDOCRINE PRACTICE, 2011, 17 (06) : 873 - 879
  • [27] Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, vitamin D and vitamin K in postmenopausal osteoporosis
    Ishida, Y
    Kawai, S
    BONE, 2003, 32 (05) : S220 - S220
  • [28] Bone turnover marker reductions after 24 months of treatment with risedronate: results from the risedronate male osteoporosis study
    Boonen, S.
    Garnero, P.
    Guo, C-Y.
    Eusebio, R.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S24 - S24
  • [29] Bone turnover marker reductions after 24 months of treatment with risedronate: Results from the risedronate male osteoporosis study
    Boonen, S.
    Garnero, P.
    Guo, C. Y.
    Eusebio, R.
    Delmas, P. D.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S119 - S119
  • [30] VITAMIN-D-RECEPTOR ALLELES, BONE-MINERAL DENSITY AND BONE TURNOVER IN JAPANESE
    TOKITA, A
    TAWA, T
    MIURA, Y
    YABUTA, K
    MATSTUMOTO, H
    MIURA, M
    WATANABE, T
    MORRISON, NA
    EISMAN, JA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S185 - S185